AFT Pharmaceuticals Overseas Health Check
Over recent months, we have begun tracking various data sources to monitor AFT Pharmaceuticals (AFT) progress in its key offshore markets.
152 Views
AFT Pharmaceuticals 1H26 Result—Bloody Good Half
We believe the AFT investment case of: (1) strong, defensive, diversified medium-term ANZ earnings growth (five-year CAGR of ~+24%); and (2) long...
266 Views
Company Coverage Temporary Coverage Changes
We make a number of temporary changes to our company coverage responsibilities with immediate effect due to Matt Montgomerie's period of...
117 Views
AFT Pharmaceuticals FY25 Result—Edging Ahead
AFT Pharmaceuticals' core ANZ business continues to perform strongly, with Australia being the highlight and margin expansion observed.
235 Views
AFT Pharmaceuticals - 1H25 Result; No Pain, No Gain
Following a weak update three weeks ago, AFT Pharmaceuticals' (AFT) 1H25 result had few surprises and we have again materially downgraded our...
452 Views